---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042902"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:29:18.477625+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics closes $1.1M private placement, exchanges debt for equity, addresses Nasdaq compliance

## Summary
- Stockholders approved issuance of shares for September 2024 transactions at Oct 29 annual meeting.
- Closed private placement: issued 1,401,994 shares + 115,000 pre-funded warrants; gross proceeds $1.1M.
- Exchange transactions: issued 38,302,029 shares for outstanding warrants and convertible notes.
- Bridge notes converted: 6,244,237 shares + 1,764,000 pre-funded warrants; $0.50 conversion price.
- Post-closing cap: ~51.4M shares outstanding; Nasdaq hearing on Nov 12 to address equity compliance.

## SEC filing metadata
- accession: 0001493152-24-042902
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 3.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315224042902/0001493152-24-042902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315224042902/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042902
- JSON: https://secwatch.observer/filing/0001493152-24-042902.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042902.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.